期刊
AMERICAN JOURNAL OF PATHOLOGY
卷 171, 期 3, 页码 882-892出版社
AMER SOC INVESTIGATIVE PATHOLOGY, INC
DOI: 10.2353/ajpath.2007.070220
关键词
-
类别
资金
- NICHD NIH HHS [K08 HD43839, K08 HD043839] Funding Source: Medline
- NIDDK NIH HHS [K01 DK075386, R37 DK035932, DK-42086, KO1 DK075386, K01 DK075386-02, P30 DK042086, DK-35932] Funding Source: Medline
AvrA is a newly described bacterial effector existing in Salmonella. Here, we test the hypothesis that AvrA is a deubiquitinase that removes ubiquitin from two inhibitors of the nuclear factor-kappa B (NF-kappa B) pathway, I kappa B alpha and beta-catenin, thereby inhibiting the inflammatory responses of the host. The role of AvrA was assessed in intestinal epithelial cell models and in mouse models infected with AvrA-deficient and -sufficient Salmonella strains. We also purified AvrA and AvrA mutant proteins and characterized their deubiquitinase activity in a cell-free system. we investigated target gene and inflammatory cytokine expression, as well as effects on epithelial cell proliferation and apoptosis induced by AvrA-deficient and -sufficient bacterial strains in vivo. Our results show that AvrA blocks degradation of I kappa B alpha and beta-catenin in epithelial cells. AvrA deubiquitinates I kappa B alpha, which blocks its degradation and leads to the inhibition of NF-kappa B activation. Target genes of the NF-kappa B pathway, such as interleukin-6, were correspondingly down-regulated during bacterial infection with Salmonella expressing AvrA. AvrA also deubiquitinates and thus blocks degradation of beta-catenin. Target genes of the beta-catenin pathway, such as c-myc and cyclinD1, were correspondingly up-regulated with AvrA expression. increased beta-catenin further negatively regulates the NF-kappa B pathway. Our findings suggest an important role for AvrA in regulating host inflammatory responses through NF-kappa B and beta-catenin pathways.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据